---
layout: post
title: "复星医药(02196)：参与认购的基金完成私募投资基金备案"
date: 2022-04-19 17:39:34 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02196" data-code="02196|116|5" data-code2="02196|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02196&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02196_0" data-code="K 02196|116|5" data-code2="K 02196|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>复星医药(02196)发布公告，就此前认购南京暾智宇澄创业投资合伙企业(有限合伙)的基金份额。近日，公司收到通知，目标基金已在中国证券投资基金业协会完成备案。<br /></p><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204192348503081>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)